Moderna Stock Jumps on Canadian Government's Approval of Updated COVID-19 Vaccine
Key Takeaways Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 vaccine.Moderna's Spikevax KP.2 targets the KP.2 variant of the virus.The U.S. Food and Drug Administration has also approved the shot,
Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older
SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians
Health Canada approves updated Moderna COVID-19 vaccine
We apologize, but this video has failed to load. The mRNA vaccine, called Spikevax, has been reformulated to target the KP.2 subvariant of Omicron, the agency said. It replaces the previous ...
Moderna Gets Canada Approval for Updated Covid-19 Vaccine
The biotechnology company on Tuesday said that Health Canada authorized the vaccine targeting the KP.2 Covid-19 variant of Sars-Cov-2. Moderna will begin delivery of updated doses to the Public Health Agency of Canada,
COVID-19 2024 fall guide: Everything Canadians should know about new Moderna vaccine, current variants and more
An updated COVID-19 vaccine is coming to Canada just in time for fall. On Tuesday, Health Canada announced it had approved Moderna’s latest COVID vaccine that’s been reformulated to target prevalent variants like KP.
Latest COVID variant, XEC, has spread to half of US states, reports say
The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...
Moderna: Still Bullish View
Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...
Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?
With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...
Raleigh News & Observer29d
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2
Spikevax 2024-2025 formula expected to be available in pharmacies and care settings across the U.S. in the days immediately following approval CAMBRIDGE, MA / ACCESSWIRE / August 22, 2024 ...
Moderna R&D Day Highlights Progress and Strategic Priorities
Focuses on ten product approvals through 2027Expects to submit next-generation COVID vaccine for approval in 2024Expects to submit flu/COVID ...
Yahoo Finance14d
MRNA Gets Positive CHMP Opinion for Updated COVID-19 Jab
Image Source: Zacks Investment Research Spikevax, targeting the variant JN.1., is currently approved in the United States, the United Kingdom, Japan and Taiwan. Last month, the FDA approved ...